Menu
Truman VA acquires VECTor preclinical imaging system featuring exclusive multimodal synergy capabilities.
Columbia, Missouri, USA and Utrecht, the Netherlands April 9th, 2020 Harry S. Truman Memorial Veterans’ Hospital’s research program is nationally recognized, in part, because of its Biomolecular Imaging Center (BIC). Using the latest imaging technology, ...
Read More →
Cyprus-based EPOS-Iasis acquires MILabs innovative Optical/CT system
Aimed at achieving a paradigm shift in Oncology research by imaging and quantifying fluorescent signals deep in the brain of animal models and to quantitate the molecular response of biomarkers to therapy February 3, 2020¶ ...
Read More →
MILabs enhances micro-CT for Coronavirus (COVID-19) research
March 19, 2020 – Utrecht, the Netherlands Based on recent scientific research, diagnostic X-ray CT is able to detect COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2), in individuals with high clinical suspicion of ...
Read More →
The Julius Wolf Institute at the Charité installs mission-critical MILabs microCT for in-vivo studies of musculoskeletal regeneration
25 February 2020 – Berlin-Germany and Utrecht, Netherlands, The Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration at the Charité – Universitätsmedizin Berlin has installed a MILabs extra ultra-high resolution microCT (U-CT XUHR) system as ...
Read More →
MILabs realizes a breakthrough in preclinical oncology imaging by eliminating the positron range effect of 89Zr-immunoPET
February 15, 2020 – Utrecht, the Netherlands Researchers at MILabs B.V. have succeeded at imaging the popular Zirconium-89 (89Zr) isotope in small animals of human disease at very high resolutions (<0.75 mm). 89Zr as used ...
Read More →
The University of Lausanne installs a high-end MILabs’ Duet Optical Imager in its core In-Vivo Imaging Laboratory
Lausanne-Switzerland and Utrecht-the Netherlands, 14 February 2020 The University of Lausanne (UNIL) and the Lausanne University Hospital (CHUV) have acquired MILabs latest in-vivo optical imaging and diagnostic X-ray CT systems. The systems will be installed ...
Read More →
Lund University Bioimaging Center (LBIC) extends its preclinical imaging capabilities with MILabs’ new diagnostic X-Ray CT system.
January 6, 2020 – Lund-Sweden and Utrecht, the Netherlands The Bioimaging Center of Lund University is a leading trans-faculty research center that houses a wide range of advanced preclinical and clinical imaging equipment. To further ...
Read More →
Kawasaki Medical University installs first MILabs E-Class U-SPECT6/CT in Japan
Kurashiki, Okayama, Japan and Utrecht, the Netherlands, 20 August 2019. Kawasaki Medical University, Yokohama’s research hub for state-of-the-art medical science and services has acquired an ultra-high-resolution E-Class U-SPECT6/CT system for preclinical imaging. E-Class stands for ...
Read More →
The Innovation Center for Translational Imaging of Tel Aviv University acquires MILabs VECTor PET/SPECT/CT system
The Innovation Center for Translational Imaging of Tel Aviv University acquires MILabs VECTor PET/SPECT/CT system Tel Aviv and Utrecht, July 8, 2019 – Tel Aviv University’s (TAU) new Translational Medical Research Center has acquired a ...
Read More →
UT Dallas acquires new microCT-enhanced deep-tissue Optical Imaging system.
The Department of Bioengineering at UT Dallas is adding a MILabs Hybrid OI/CT system to its innovative medical imaging solutions. By fusing bioluminescent and fluorescent imaging with ultra-high-resolution CT, this new in-vivo imaging system enables ...
Read More →
